Janus Henderson Group PLC F Star Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $182 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.77 - $5.36 $1.45 Million - $2.8 Million
-522,158 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.71 - $7.38 $735,857 - $1.15 Million
-156,233 Reduced 23.03%
522,158 $2.63 Million
Q3 2021

Nov 16, 2021
SELL
$5.2 - $8.42 $186,648 - $302,227
-35,894 Reduced 5.03%
678,391 $4.94 Million
Q2 2021

Aug 16, 2021
BUY
$6.57 - $10.71 $4.69 Million - $7.65 Million
714,285 New
714,285 $6.1 Million

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email